PAX-BD Pramipexole Trial for Bipolar Depression primary logo
About
Study background Recruiting sites PPI
News Participants
Study summary How to join the study Info for study participants
Staff info
Links for staff Training videos Newsletters Site support
Study team Contact

News

2021

12 January 2021 News category

New Year – New Sites and New Participants!
Read more
Documents 4

10 November 2020 Study Documents and Training

Study documents
Read more
News

10 November 2020 News category

The PAX-BD study - COVID-19 information for study staff
Read more
News 3

10 November 2020 News category

The PAX-BD study - COVID-19 information for participants
Read more
Celebration 6

10 November 2020 News category

First participant recruited
Read more
FA Qs

20 October 2020 Study Documents and Training

New staff document
Read more
Celebration 2

13 October 2020 News category

CNTW and Nottingham sites are now open!
Read more
Training 1

05 October 2020 PAX-BD Trial Management

PAX-BD - Re-start training for sites
Read more
Celebration 1

05 October 2020 News category

PAX-BD is now re-open!
Read more
Popular posts
Categories
  • News category (6)
  • PAX-BD Trial Management (1)
  • Study Documents and Training (2)
Pramipexole Trial for Bipolar Depression logo
Pramipexole Trial for Bipolar Depression

A randomised, double-blind, placebo controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression

Popular posts
Get in touch

PAX-BD Trial
Newcastle Clinical Trials Unit,
Newcastle University,
1-4 Claremont Terrace,
Newcastle upon Tyne, NE2 4AE

PAX.BD@newcastle.ac.uk

(0191) 208 2598

©2023 PAX-BD. All rights reserved.

Designed by 10 Creative